スポーツテック企業のユーフォリアが、臨床検査の世界的リーダーであるシスメックスと資本・業務提携。その意図は単純だが、遅きに失した感がある......。
bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…
Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…
Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to…
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering…
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of…
bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…
Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…
Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to…
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering…
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of…
アカウントにサインインする